CMANY
PFE icon

Capital Management Associates (New York)’s Pfizer PFE Stock Holding History

Capital Management Associates (New York)’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-450
Closed -$11.9K – 56
2024
Q4 		$11.9K Hold
450
– – 0.01% 66
2024
Q3 		$13K Hold
450
– – 0.01% 71
2024
Q2 		$12.6K Hold
450
– – 0.01% 67
2024
Q1 		$12.5K Hold
450
– – 0.01% 71
2023
Q4 		$13K Sell
450
-800
-64% -$24.2K 0.02% 75
2023
Q3 		$41K Hold
1,250
– – 0.06% 70
2023
Q2 		$45.9K Sell
1,250
-490
-28% -$19.1K 0.07% 67
2023
Q1 		$71K Sell
1,740
-374
-18% -$16.2K 0.11% 64
2022
Q4 		$108K Sell
2,114
-26,997
-93% -$1.29M 0.16% 59
2022
Q3 		$1.27M Sell
29,111
-235
-0.8% -$11.4K 1.85% 19
2022
Q2 		$1.54M Sell
29,346
-6,406
-18% -$326K 2.27% 11
2022
Q1 		$1.85M Buy
35,752
+21,765
+156% +$1.13M 1.99% 13
2021
Q4 		$826K Buy
13,987
+430
+3% +$21.3K 0.81% 53
2021
Q3 		$583K Hold
13,557
– – 0.57% 59
2021
Q2 		$531K Sell
13,557
-800
-6% -$31.1K 0.51% 60
2021
Q1 		$520K Sell
14,357
-750
-5% -$26.6K 0.54% 66
2020
Q4 		$556K Sell
15,107
-1,343
-8% -$49.3K 0.61% 63
2020
Q3 		$573K Sell
16,450
-738
-4% -$25.9K 0.76% 51
2020
Q2 		$533K Sell
17,188
-5,375
-24% -$183K 0.75% 51
2020
Q1 		$699K Buy
22,563
+4,032
+22% +$137K 1.26% 32
2019
Q4 		$689K Sell
18,531
-1,282
-6% -$45.7K 0.95% 44
2019
Q3 		$675K Buy
19,813
+3,916
+25% +$142K 1.04% 35
2019
Q2 		$653K Sell
15,897
-1,371
-8% -$54.4K 1.06% 34
2019
Q1 		$696K Buy
17,268
+106
+0.6% +$4.25K 1.08% 29
2018
Q4 		$711K Sell
17,162
-1,476
-8% -$61.3K 1.35% 23
2018
Q3 		$779K Buy
18,638
+211
+1% +$8.12K 0.97% 32
2018
Q2 		$634K Hold
18,427
– – 0.79% 52
2018
Q1 		$620K Sell
18,427
-1,159
-6% -$39.8K 0.95% 33
2017
Q4 		$673K Hold
19,586
– – 0.96% 35
2017
Q3 		$663K Sell
19,586
-211
-1% -$6.78K 0.94% 37
2017
Q2 		$631K Hold
19,797
– – 0.95% 35
2017
Q1 		$643K Sell
19,797
-1,402
-7% -$44.2K 0.96% 35
2016
Q4 		$653K Sell
21,199
-2,863
-12% -$87.4K 1.02% 30
2016
Q3 		$773K Sell
24,062
-29
-0.1% -$970 1.22% 19
2016
Q2 		$805K Buy
24,091
+2,108
+10% +$67.3K 1.37% 16
2016
Q1 		$618K Sell
21,983
-51
-0.2% -$1.46K 1.12% 31
2015
Q4 		$675K Sell
22,034
-1,370
-6% -$43.1K 0.98% 32
2015
Q3 		$697K Sell
23,404
-949
-4% -$30.4K 1.07% 27
2015
Q2 		$775K Sell
24,353
-316
-1% -$10.3K 1.02% 25
2015
Q1 		$814K Sell
24,669
-2,287
-8% -$72.7K 1.08% 22
2014
Q4 		$797K Buy
26,956
+949
+4% +$27.2K 1.17% 19
2014
Q3 		$730K Buy
26,007
+8,590
+49% +$241K 1.1% 16
2014
Q2 		$490K Sell
17,417
-238
-1% -$6.78K 0.72% 62
2014
Q1 		$538K Buy
17,655
+3,584
+25% +$107K 0.78% 52
2013
Q4 		$409K Sell
14,071
-392
-3% -$11.4K 0.6% 83
2013
Q3 		$394K Buy
14,463
+1,080
+8% +$29.4K 0.6% 86
2013
Q2 		$356K Buy
+13,383
New +$370K 0.58% 84

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Management Associates (New York)'s PFE Position: Q1 2025 in Review

Capital Management Associates (New York) sold out of Pfizer (PFE) in Q1 2025, closing a stake of 450 shares — an estimated $11.9K sold.

Capital Management Associates (New York) first reported a position in PFE in Q2 2013 and held it in 47 quarters. The position peaked at $1.85M in Q1 2022. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Capital Management Associates (New York) reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • Capital Management Associates (New York) sold 450 Pfizer shares in Q1 2025, an estimated $11.9K.
  • Capital Management Associates (New York) first reported a position in Pfizer in Q2 2013 and held it in 47 quarters.
  • Capital Management Associates (New York)'s Pfizer position peaked at $1.85M in Q1 2022.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Capital Management Associates (New York)'s 13F filing for Q1 2025, filed 8 May 2025.